Transgenic models of diabetes.
Sarvetnick
N
N
Department of Neuropharmacology, Scripps Clinic and Research Foundation, La Jolla, California.
D000818:Animals; D001327:Autoimmune Diseases / Q000235:genetics / Q000276:immunology*; D003921:Diabetes Mellitus, Experimental / Q000235:genetics / Q000276:immunology*; D003922:Diabetes Mellitus, Type 1 / Q000235:genetics / Q000276:immunology*; D004195:Disease Models, Animal; D005786:Gene Expression Regulation; D006649:Histocompatibility Antigens / Q000096:biosynthesis / Q000235:genetics / Q000276:immunology; D006801:Humans; D007371:Interferon-gamma / Q000096:biosynthesis; D007515:Islets of Langerhans / Q000276:immunology / Q000378:metabolism; D051379:Mice; D008822:Mice, Transgenic / Q000276:immunology*; D008954:Models, Biological; D011994:Recombinant Proteins / Q000096:biosynthesis
D006649:Histocompatibility Antigens; D011994:Recombinant Proteins; D007371:Interferon-gamma